157 related articles for article (PubMed ID: 38718119)
1. Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer.
Fan Y; Ye J; Kang Y; Niu G; Shi J; Yuan X; Li R; Han J; Ji X
Sci Adv; 2024 May; 10(19):eadm9561. PubMed ID: 38718119
[TBL] [Abstract][Full Text] [Related]
2. Piezoelectric Catalysis Induces Tumor Cell Senescence to Boost Chemo-Immunotherapy.
Hao Z; Guo S; Tu W; Wang Q; Wang J; Zhang X; He Y; Gao D
Small; 2024 Jun; 20(25):e2309487. PubMed ID: 38197548
[TBL] [Abstract][Full Text] [Related]
3. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
4. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic nanodrug blocks CD73 to inhibit adenosine and boosts antitumor immune response synergically with photothermal stimulation.
Li T; Zhang X; Shi C; Liu Q; Zhao Y
J Nanobiotechnology; 2024 Apr; 22(1):214. PubMed ID: 38689291
[TBL] [Abstract][Full Text] [Related]
6. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
7. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
[TBL] [Abstract][Full Text] [Related]
8. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
Jang Y; Cho YS; Kim A; Zhou X; Kim Y; Wan Z; Moon JJ; Park H
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17129-17144. PubMed ID: 38533538
[TBL] [Abstract][Full Text] [Related]
9. A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy.
Wang H; Wu C; Tong X; Chen S
J Control Release; 2023 Jan; 353():727-737. PubMed ID: 36473607
[TBL] [Abstract][Full Text] [Related]
10. Genetically Engineering Cell Membrane-Coated BTO Nanoparticles for MMP2-Activated Piezocatalysis-Immunotherapy.
Tang Q; Sun S; Wang P; Sun L; Wang Y; Zhang L; Xu M; Chen J; Wu R; Zhang J; Gong M; Chen Q; Liang X
Adv Mater; 2023 May; 35(18):e2300964. PubMed ID: 36809650
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line.
Asadirad A; Baghaei K; Hashemi SM; Dehnavi S; Ghanbarian H; Mortaz E; Anissian A; Asadzadeh Aghdaei H; Amani D
Int Immunopharmacol; 2022 Mar; 104():108493. PubMed ID: 35032826
[TBL] [Abstract][Full Text] [Related]
12. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
13. A Biomimetic Aggregation-Induced Emission Photosensitizer with Antigen-Presenting and Hitchhiking Function for Lipid Droplet Targeted Photodynamic Immunotherapy.
Xu X; Deng G; Sun Z; Luo Y; Liu J; Yu X; Zhao Y; Gong P; Liu G; Zhang P; Pan F; Cai L; Tang BZ
Adv Mater; 2021 Aug; 33(33):e2102322. PubMed ID: 34247428
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer.
He H; Liu L; Liang R; Zhou H; Pan H; Zhang S; Cai L
Acta Biomater; 2020 Mar; 104():188-197. PubMed ID: 31945508
[TBL] [Abstract][Full Text] [Related]
15. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
[TBL] [Abstract][Full Text] [Related]
16. Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade.
Liu W; Wu J; Ji X; Ma Y; Liu L; Zong X; Yang H; Dai J; Chen X; Xue W
Theranostics; 2020; 10(14):6245-6260. PubMed ID: 32483451
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment.
Li J; Zhao M; Sun M; Wu S; Zhang H; Dai Y; Wang D
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50734-50747. PubMed ID: 33124808
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
[TBL] [Abstract][Full Text] [Related]
19. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
20. Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy.
Wang X; Wang N; Yang Y; Wang X; Liang J; Tian X; Zhang H; Leng X
Biomater Sci; 2019 Jun; 7(7):3062-3075. PubMed ID: 31140475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
